|Place of Origin:||CHINA|
|Certification:||GMP , ISO 9001:2008|
|Minimum Order Quantity:||1g|
|Packaging Details:||Stealth and discreet packaging|
|Delivery Time:||Usually within 7 work days|
|Payment Terms:||Bank Transfer - Bitcoin - Western Union - MoneyGram|
|Supply Ability:||1 KG/Month|
pharmaceutical active ingredients,
pharmaceutical anabolic steroids
Product Name: Bimatoprost
Shelf life:2 Years Proper Storage
Type: Pharmaceutical Intermediates
|Other Pharmaceutical Intermediate|
|Flibanserin/Bimt 17/||167933-07-5||Flibanserin HCl||147359-76-0|
|Corey lactone||69222-61-3||Tianeptine Sodium||30123-17-2|
|Terbinafine Hydrochloride||78628-80-5||Miconazole nitrate||22832-87-7|
Bimatoprost is a synthetic amide F2α derivative ,it can selectively simulate the effect forefront amines produced by the body, which make aqueous humor production rate increase aqueous outflow resistance is reduced, by increasing the amount of aqueous outflow of the uveoscleral and trabecular Netcom channel to reduce intraocular pressure (IOP),it is considered to be the most effective hypotensive drug of topical ocular anti-glaucoma drugs,it is suitable for the treatment of open-angle glaucoma (POAG) or invalid elevated intraocular other ocular hypotensive medications compression syndrome (OHT) patients.
Chemical Properties: Crystalline Solid
Uses Antiglaucoma. Synthetic prostamide; structurally related to prostaglandin F2a.
Uses Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes.
Uses Bimatoprost is an antiglaucoma agent. Bimatoprost is an synthetic prostamide; structurally related to prostaglandin F2α.
Uses 17-phenyl trinor Prostaglandin F2α ethyl amide (17-phenyl trinor PGF2α ethyl amide) is an F-series PG analog which has been approved for use as an ocular hypotensive drug. Investigations in our lab have shown that 17-phenyl trinor PGF2α ethyl amide is converted by an amidase enzymatic activity in the bovine and human cornea to yield the corresponding free acid, with a conversion rate of about 40 μg/g corneal tissue/24 hours. The free acid, 17-phenyl trinor PGF2α, is a potent FP receptor agonist.
Bimatoprost reduces pressure in the eye by increasing the amount of fluid that drains from the eye.
Bimatoprost ophthalmic (for the eyes) is used to treat certain types of glaucoma and other causes of high pressure inside the eyes.
Bimatoprost ophthalmic may also be used for purposes not listed in this medication guide.
Bimatoprost is used for the treatment of open-angle glaucoma and ocular hypertension in adult patients, either alone or in combination with a beta blocker (typically timolol).
Studies have shown bimatoprost to be more effective than timolol in reduction of intraocular pressure (IOP) and as least as effective as the prostaglandin analogs latanoprost and travoprost in reducing IOP.
Bimatoprost is a prostaglandin analog/prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes.The cosmetic formulation of bimatoprost is sold as Latisse. In 2008-2011, at least three case series suggested that bimatoprost has the ability to reduce adipose (fat) tissue.
Remember to use the drops every day.
The drops can alter the colour of your eyes over time, and cause your eyelashes to grow darker and thicker.